months at one centre were assessed. Patients were excluded if (a) the original indication was not UC (n=5), (b) the excised pouch showed histology diagnostic of Crohn's disease (n=2), and (c) data were inadequate (n=4). Smoking data were collected by questionnaire, or direct interview, or both. Ex-smokers were those who had stopped smoking <7 years before colectomy. Non-smokers included exsmokers who had stopped >7 years before colectomy. Pouchitis was defined as an increase in stool frequency >8/day with acute inflammation on biopsy specimen histology. Each presentation requiring treatment was regarded as an episode. For comparison smoking habit was assessed with regard to three other adverse outcomes -haemorrhage, sepsis, and pouch excision. Of 72 non-smokers (mean follow up 3*5 years) 18 Smoking data were collated by questionnaire (n=73) and direct interview (n= 93) over a two year period. Ex-smokers were patients who had given up less than seven years prior to proctocolectomy. Non-smokers included exsmokers who had given up more than seven years prior to proctocolectomy as well as lifelong non-smokers. Two patients had a sustained change in smoking habit after IPAA and the occurrence of pouchitis was related to the smoking habit at that time. All patients were followed up at designated clinics at one hospital and were followed up for two years (1990) (1991) (1992) by one investigator (MM). For the purposes of this study pouchitis was defined as an increase in stool frequency to at least 8/day with biopsy specimen histology showing pronounced inflammation -that is, histopathology index -7.23 Patients usually had general malaise with occasional per anal bleeding and extraintestinal manifestations. Microbiological studies of stool were obtained routinely to exclude a specific pathogen as a cause for the diarrhoea. Each presentation requiring treatment was regarded as an episode. For comparison smoking habit was assessed against other adverse outcomes in this same patient group. These included haemorrhage, sepsis, and pouch excision. 30 and unrecognised Crohn's disease.
The protective role of smoking against UC is well reported.1-9 However, this is the first report of smoking habit in relation to the incidence of pouchitis. Our finding that smoking is protective against the subsequent onset of pouchitis needs to be confirmed with a larger series, but pouchitis needs to be accurately defined and include histological criteria. The mechanism(s) by which smoking protects against intestinal inflammation (UC) are unknown. Smoking has been reported to affect mucosal immune function in both the respiratory tract31-33 and gastrointestinal tract34 although in the last study only minor differences in IgA concentrations were identified. Smoking also affects mucus production35 and rectal blood flow,34 however the significance of these reports is unknown. Perhaps the most important finding is that smoking reduces mucosal permeability as measured by urinary recovery of 51chromium-EDTA.36
Regardless of the mechanism the finding that smoking (and probably nicotine) protects against pouchitis raised the possibility of therapeutic intervention. We have shown that barrier function (51chromium-EDTA permeation) is low in preclosure ileal pouch, which suggests that the ileal mucosa is at greatest risk in the first few weeks when exposed to a large antigen/toxin faecal load. ' 
